BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 12832243)

  • 1. Insurance expenditures on bipolar disorder: clinical and parity implications.
    Peele PB; Xu Y; Kupfer DJ
    Am J Psychiatry; 2003 Jul; 160(7):1286-90. PubMed ID: 12832243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in mental health insurance benefits and out-of-pocket spending.
    McKusick DR; Mark TL; King EC; Coffey RM; Genuardi J
    J Ment Health Policy Econ; 2002 Jun; 5(2):71-8. PubMed ID: 12529560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health spending by private insurance: implications for the mental health parity and addiction equity act.
    Mark TL; Vandivort-Warren R; Miller K
    Psychiatr Serv; 2012 Apr; 63(4):313-8. PubMed ID: 22476300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
    Guo JJ; Keck PE; Li H; Patel NC
    Psychiatr Serv; 2007 Aug; 58(8):1073-8. PubMed ID: 17664518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting to outpatient care? Mental health care use and cost under private insurance.
    Leslie DL; Rosenheck R
    Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care utilization and costs among privately insured patients with bipolar I disorder.
    Bryant-Comstock L; Stender M; Devercelli G
    Bipolar Disord; 2002 Dec; 4(6):398-405. PubMed ID: 12519100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.
    Dusetzina SB; Farley JF; Weinberger M; Gaynes BN; Sleath B; Hansen RA
    Psychiatr Serv; 2012 Oct; 63(10):1019-25. PubMed ID: 22855210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council.
    Am J Psychiatry; 1993 Oct; 150(10):1447-65. PubMed ID: 8379547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national profile of health care utilization and expenditures for children with special health care needs.
    Newacheck PW; Kim SE
    Arch Pediatr Adolesc Med; 2005 Jan; 159(1):10-7. PubMed ID: 15630052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-pocket health expenditures in patients with bipolar disorder, anxiety, schizophrenia and other psychotic disorders: findings from a study in a psychiatry outpatient clinic in Turkey.
    Islek D; Kilic B; Akdede BB
    Soc Psychiatry Psychiatr Epidemiol; 2018 Feb; 53(2):151-160. PubMed ID: 29184969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of medical and behavioral health services by adolescents with bipolar disorder.
    Peele PB; Axelson DA; Xu Y; Malley EE
    Psychiatr Serv; 2004 Dec; 55(12):1392-6. PubMed ID: 15572567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expenditures for the treatment of major depression.
    Rost K; Zhang M; Fortney J; Smith J; Smith GR
    Am J Psychiatry; 1998 Jul; 155(7):883-8. PubMed ID: 9659851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis.
    Williams MD; Shah ND; Wagie AE; Wood DL; Frye MA
    Psychiatr Serv; 2011 Sep; 62(9):1073-8. PubMed ID: 21885587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth in Spending on and Use of Services for Mental and Substance Use Disorders After the Great Recession Among Individuals With Private Insurance.
    Mark TL; Hodgkin D; Levit KR; Thomas CP
    Psychiatr Serv; 2016 May; 67(5):504-9. PubMed ID: 26725293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.